How do the two Oath Research codes apply to Melanotan 2?

GRANT gives new customers 20% off their first order of Melanotan 2 at oathresearch.com. GRANT15 gives every customer 15% off any order.

Melanotan 2 changes the pigment conversation

A change in skin colour is easy to notice. It takes a closer look to understand what that change does—and doesn’t—tell us.

Oath Research code terms Open the conditions and research-material card

Current order-code terms for Melanotan 2

These codes are current. This site receives no payment from orders using them.

GRANT gives 20% off for new customers on their first order. New customers only. First order.

GRANT15 gives 15% off for everyone on any order. No minimum. Applies to repeat orders.

Oath Research lists Melanotan 2 as research material. These are brand-level order codes, not an offer of medical care or material for human use.

Oath Research Melanotan 2, sold as research material at oathresearch.com

Sunlight grazing cream paper folds and a soft shadow on a pale wall

Why researchers study it

Melanotan 2, also written Melanotan II, is a synthetic peptide: a short chain of amino acids. It activates several melanocortin receptors, parts of cells that respond to chemical signals. One is involved in making skin pigment.

Scientists use it as a tool for studying those signals. A useful research tool isn’t automatically a safe tanning treatment. It can help answer a question about cells without settling what repeated use might mean for a person.

Its research history connects it to PT-141. I keep skin and desire on separate pages so each question has room, without borrowing the other compound’s findings.

What a darker appearance can’t tell you

Melanotan 2 has no FDA-approved use. Related medicines have their own approvals, but those don’t apply to it. Similar names can make that easy to miss when you’re reading quickly.

A tan can’t show whether a mole is harmless or whether long-term use is safe. The skin reports deserve a closer look.

Take the mole reports seriously, without overstating them

A review of unregulated melanotan use describes changing moles, new abnormal moles and cases of melanoma. It covers melanotan I and II. The reports don’t prove melanotan caused the cancers, and they don’t tell us how often such harm occurs.

New or changing moles warrant timely assessment by a skin specialist. A general page can explain the concern; it can’t judge your own skin.

There are other safety concerns too

A case report and review describes a kidney injury associated with Melanotan 2: blood supply to part of the kidney was cut off. It also discusses reports of severe muscle breakdown. These are warnings about possible serious harm, not a measured risk for every user.

On FDA’s page current as of April 22, 2026, melanotan II appears among nominations that were withdrawn. The request was taken back; FDA didn’t clear the substance. Withdrawal isn’t approval for compounding or a move into Category 1.

The research-material terms above are separate from this health discussion. A listing doesn’t establish approval or safety for personal use.

The shared history leads back to two different questions. Skin pigment and desire each need their own evidence.

See why the evidence stays separate